KOSPIInsurance085620

MIRAE ASSET Life Insurance

₩17,640▲ 5.57%2026-11-18 close
Market Cap
₩2.4T
Turnover
₩1.8B
Volume
100K
Shares out.
140M
PER
52.1×
PBR
1.0×
EPS
₩318
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Health-protection CSM grows as Q3 2026 turns to a loss

Held contractual service margin (CSM) rose to KRW 2.32 trillion at the end of Q3 2026, but a regulatory assumption change and investment losses pushed the quarter to an operating loss and a net loss.

  1. 1

    Insurance revenue rose two years in a row through 2025 to KRW 1.08 trillion, and the DART quarterly figures show four consecutive quarterly increases from Q4 2025 through Q3 2026.

  2. 2

    Q3 2026 recorded an operating loss of KRW 43.1 billion and a net loss attributable to controlling shareholders of KRW 33.9 billion, with the regulatory change reducing cumulative insurance profit by KRW 70.7 billion.

  3. 3

    Health and accident insurance new-contract CSM reached KRW 348.9 billion in the first nine months of 2026, up 10.6% year on year, and accounted for 84.9% of total new-contract CSM.

  4. 4

    The K-ICS solvency ratio was an estimated 147.3% at the end of Q3 2026, down 29.4 percentage points from year-end 2025, with rising market interest rates cited as a main factor.

  5. 5

    Controlling-shareholder net income for the last four quarters totals KRW 43 billion, so the gap between the share price and the earnings base is the central variable in valuation reading.

02

Business structure

MIRAE ASSET Life Insurance is a listed life insurer whose business is organized around three areas: health and accident protection, variable insurance, and retirement pensions.

Cumulative first-nine-month 2026 protection new-business annualized premium equivalent (APE) reached KRW 293.8 billion, up 23.5% from a year earlier. Health and accident insurance accounted for KRW 348.9 billion of new-contract CSM in the same period, or 84.9% of the total, compared with 79.6% a year earlier.

Because the new-business mix has shifted toward health and accident products, the base of contractual service margin that is recognized as profit over the contract period has widened. Variable insurance reserves rose 10.8% to KRW 14.194 trillion, and variable insurance fee income rose 21.0% to KRW 45.7 billion.

Defined-contribution and individual retirement pension reserves reached KRW 2.303 trillion, up 11.7%. Held CSM at the end of Q3 2026 was KRW 2.32 trillion on a consolidated basis, up 12.7% from year-end 2025.

According to the company's earnings commentary, expansion of protection sales through general insurance agencies (GA) channels contributed to the improvement. Management has put loss-ratio control, profitability-focused new business, and asset-liability management (ALM) at the center of its quality-growth strategy.

Health and accident products anchor the protection portfolio, while variable products support fee income. Profit is split between insurance service results and investment results, and investment results were highly sensitive to alternative-asset valuation losses and currency moves.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩275B₩61.8B22.5%
2025Q4₩284.5B₩28.3B10.0%
2026Q1₩288.1B₩68.4B23.7%
2026Q2₩306.3B₩23.6B7.7%
2026Q3₩322.6B-₩43.1B−13.4%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩903.9B₩162.4B₩124.8B—3.1%757.4%
2023₩901.6B₩169.1B₩117.2B—4.0%1036.9%
2024₩964B₩122.1B₩136.1B—5.3%1167.5%
2025₩1.1T₩194.5B₩130.8B—5.3%1244.8%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Based on disclosed results, annual insurance revenue fell from KRW 903.9 billion in 2022 to KRW 901.6 billion in 2023 (down 0.2% year over year), then rose to KRW 964.0 billion in 2024 (up 6.9% year over year) and KRW 1.0804 trillion in 2025 (up 12.1% year over year). 2025 was the largest year of 2022–2025 and 2023 was the smallest.

Operating profit was KRW 162.4 billion in 2022 and KRW 169.1 billion in 2023 (up 4.1% year over year), then turned down to KRW 122.1 billion in 2024 (down 27.8% year over year) before recovering to KRW 194.5 billion in 2025 (up 59.3% year over year).

Even though insurance revenue grew after 2024, operating profit was lowest in 2024, so the link between revenue scale and profit level was not consistent from year to year.

Net profit attributable to controlling shareholders was KRW 124.8 billion in 2022, KRW 117.2 billion in 2023 (down 6.1% year over year) and KRW 136.1 billion in 2024 (up 16.1% year over year), the highest of the period, and then KRW 130.8 billion in 2025 (down 3.9% year over year).

Net profit including non-controlling interests is reported at the same amount each year. The debt ratio (total liabilities ÷ total equity) rose from 757.4% in 2022 to 1,244.8% in 2025, and at the end of 2025 total equity was KRW 2.4481 trillion and total liabilities were KRW 30.4727 trillion.

Operating cash flow was negative at KRW -671.6 billion in 2022, KRW -990.7 billion in 2023 and KRW -253.2 billion in 2024, then turned positive at KRW 284.5 billion in 2025.

On a quarterly basis, insurance revenue grew from KRW 275.0 billion in the third quarter of 2025 to KRW 322.6 billion in the third quarter of 2026, a 17.3% increase year over year for the third quarter of 2026.

Operating profit, on the other hand, went through KRW 61.8 billion in the third quarter of 2025, KRW 28.3 billion in the fourth quarter, KRW 68.4 billion in the first quarter of 2026 and KRW 23.6 billion in the second quarter, before swinging to an operating loss of KRW 43.1 billion in the third quarter.

The company cited as the reasons for the third-quarter loss the impact of a regulatory change from applying the actuarial assumption guidelines of KRW 70.7 billion (on a cumulative insurance profit basis), an investment loss (KRW 9.2 billion cumulative) due to valuation losses on alternative investments and other items, and exchange rate movements.

Cumulative insurance profit excluding the impact of the regulatory change was KRW 125.2 billion, up from KRW 117.9 billion in the same period a year earlier. Cumulative net profit for the same period was KRW 37.5 billion, down 70.1% year over year (as announced on November 13, 2026).

05

Industry analysis

Life insurers are in a phase where the regulatory assumption guidelines applied by the financial authorities are feeding one-time effects into insurance profit. At MIRAE ASSET Life Insurance, that effect was KRW 70.7 billion in cumulative insurance profit through Q3 2026.

Since the adoption of IFRS 17, the industry has put more weight on securing CSM, the future profit base, than on short-term earnings, and competition on profitability centered on protection products such as health and accident coverage has become more pronounced.

On the rate side, the company attributes the decline in its solvency ratio partly to higher market interest rates. On the investment side, valuation losses on alternative assets and currency moves have been moving quarterly profit, widening the gap between insurance operations and investment results.

The company holds variable insurance reserves of KRW 14.194 trillion and retirement pension reserves of KRW 2.303 trillion, a sizable asset-linked base. In protection, it competes in the same space as large life insurers, so loss-ratio management and new-business profitability are the differentiators.

Expanding health-insurance CSM matches the industry direction, but if loss ratios worsen, the speed at which CSM turns into profit could change. Interest rates, currency moves, and actuarial assumptions are common drivers that amplify earnings swings across life insurers.

06

Outlook

In its Q3 2026 announcement, the company set out loss-ratio control, profitability-focused new business, and asset-liability management as the direction of its quality growth. Protection APE up 23.5% and held CSM up 12.7% mean the base for future contractual service margin recognized as profit has widened.

The KRW 70.7 billion regulatory-assumption effect came from the application of the financial authority's guidelines, so whether it recurs in later quarters' insurance profit needs to be confirmed. Investment results have swung sharply each quarter with alternative-asset valuation losses and currency moves.

The K-ICS solvency ratio was an estimated 147.3%, lower than at year-end, so managing capital headroom remains a task. The company said in its earnings commentary that it is pursuing AI face authentication, an AI chatbot launch, expansion of its sales network, and stronger competitiveness in the GA channel.

These digital and channel initiatives could expand new business, but they may take time to show up in reported figures.

The next scheduled confirmation point is the 2026 annual report, which will provide the confirmed full-year 2026 insurance revenue, operating profit, net income attributable to controlling shareholders, and year-end debt-to-equity ratio.

In the Q1 2027 quarterly results, the key question is how much of the regulatory effect persists in quarterly insurance profit. Overall, two factors will shape the outlook: whether growth in protection new business and held CSM continues, and whether investment results and the solvency ratio stabilize.

07

Valuation

PER
52.1×
PBR
1.0×
ROE
1.8%
EPS
₩318
BPS
₩17,108
Dividend per share
₩0

Valuation can be read through two lenses: net asset value and the earnings base. The price-to-book ratio sits around 1x, meaning the share price is trading close to book value per share. Total equity at year-end 2025 was KRW 2.45 trillion, and equity attributable to controlling shareholders was the same amount.

On an earnings basis, however, net income attributable to controlling shareholders over the last four quarters totals only KRW 43 billion, which is small relative to the market capitalization.

The price-to-earnings ratio is elevated because the earnings base has contracted, and its level will move with the pace of earnings recovery. Dividend yield is in the 0% range, so cash dividends are not a prominent source of shareholder return. Where the multiple sits within its past trading band should be read together with whether earnings recover.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Quality expansion of protection new business

Health and accident new-contract CSM reached KRW 348.9 billion in the first nine months of 2026, up 10.6%, and made up 84.9% of total new-contract CSM. Protection APE grew 23.5% to KRW 293.8 billion, so sales volume expanded alongside. The company describes this as the result of shifting the portfolio toward profitability.

Held CSM and recovery in insurance operations

Held CSM reached KRW 2.32 trillion at the end of Q3 2026, up 12.7% from year-end 2025. Cumulative insurance profit excluding the regulatory change was KRW 125.2 billion, above KRW 117.9 billion a year earlier. Insurance revenue has risen for four consecutive quarters from Q4 2025 through Q3 2026.

Two straight years of insurance revenue growth and profit recovery

Insurance revenue rose to KRW 964 billion in 2024 and KRW 1.08 trillion in 2025, two consecutive years of growth. Operating profit reached KRW 194.5 billion in 2025, up 59.3%, reversing the 2024 decline. Variable insurance fee income and retirement pension reserves also grew year on year.

09

Bear factors

Q3 swing to losses and the regulatory-change hit

Q3 2026 posted an operating loss of KRW 43.1 billion and a net loss attributable to controlling shareholders of KRW 33.9 billion. The regulatory assumption change reduced cumulative insurance profit by KRW 70.7 billion, and investment results were a KRW 9.2 billion loss.

The company attributes these to one-time factors such as currency moves and valuation losses, but the swing in earnings was large.

Lower solvency ratio

The K-ICS solvency ratio was an estimated 147.3% at the end of Q3 2026, down 29.4 percentage points from year-end 2025. Higher market interest rates were cited as a main cause. With capital headroom narrower, sensitivity to interest-rate moves is drawing attention.

Thin earnings base and high leverage

Net income attributable to controlling shareholders for the last four quarters totals KRW 43 billion. The 2025 figure fell 3.9% from 2024, and Q2 2026 came in at KRW 18 billion, down 66.3% from the prior quarter. The debt-to-equity ratio climbed from 757.4% in 2022 to 1,244.8% in 2025.

10

Risk factors

Actuarial assumption and regulatory risk

The financial authority's actuarial assumption guidelines reduced cumulative insurance profit by KRW 70.7 billion through Q3 2026. How much of this effect carries into the full-year close and later quarters has not yet been settled. If regulatory changes recur, the improvement in core insurance operations could be obscured.

Interest rate, currency and investment asset risk

Higher market interest rates pushed down the solvency ratio, and alternative-asset valuation losses and currency moves turned investment results negative. When investment swings are large, the extent to which core insurance improvement shows up in net income is limited. On the asset side, the weight of alternative investments and their valuation approach are key items to watch.

Health insurance loss-ratio risk

With health and accident products now 84.9% of new-contract CSM, loss-ratio management is the central variable for profitability. The company stresses this control, but a deterioration in loss ratios could change the quality of new CSM. The debt-to-equity ratio of 1,244.8% also limits financial cushion.

11

What to watch next

  1. Late December 2026

    Watch the year-end K-ICS solvency ratio and the interest rate backdrop. Where the Q3 estimate of 147.3% lands at year-end will show the direction of capital headroom.

  2. Late March 2027

    The 2026 annual report will confirm full-year insurance revenue, operating profit, net income attributable to controlling shareholders, and the year-end debt-to-equity ratio, along with the full-year effect of the assumption change.

  3. Mid-May 2027

    Q1 2027 quarterly report filing, where the focus is whether the regulatory effect recurs in quarterly insurance profit and whether operating results recover from the Q3 2026 loss.

12

Overall view

MIRAE ASSET Life Insurance is widening its core insurance base as health and accident-centered protection new business and held CSM grow together. Insurance revenue rose two straight years to KRW 1.08 trillion in 2025, and operating profit recovered to KRW 194.5 billion.

However, Q3 2026 turned to an operating loss of KRW 43.1 billion and a net loss attributable to controlling shareholders of KRW 33.9 billion as the regulatory effect of KRW 70.7 billion coincided with investment losses.

The solvency ratio was an estimated 147.3%, lower than at year-end, and the debt-to-equity ratio of 1,244.8% reflects a large liability base relative to equity.

Net income attributable to controlling shareholders over the last four quarters totals KRW 43 billion, so the reading of the valuation multiple depends on the pace of earnings recovery.

Strengths include improving new-business quality and consecutive growth in insurance revenue, while weaknesses include the regulatory-assumption effect, volatility in rates, currency and investment results, and the decline in the solvency ratio.

These factors should be weighed equally, and the next confirmation points are the confirmed full-year figures in the 2026 annual report and the Q1 2027 quarterly results. This report is for information only and contains no buy or sell opinion or target price.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. digitaltoday.co.kr
  2. view.asiae.co.kr
  3. digitaltoday.co.kr
  4. comp.wisereport.co.kr
  5. huffingtonpost.kr
  6. insight.goover.ai
  7. m.news.nate.com
  8. g-enews.com
  9. fntimes.com
  10. ftoday.co.kr
  11. e-science.co.kr
  12. insjournal.co.kr
  13. daily.hankooki.com
  14. dailysmart.co.kr
  15. lcnews.co.kr
  16. wolyo.co.kr
  17. joongangenews.com
  18. ezyeconomy.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis